133 related articles for article (PubMed ID: 7692442)
1. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process.
Corbett JA; Mikhael A; Shimizu J; Frederick K; Misko TP; McDaniel ML; Kanagawa O; Unanue ER
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8992-5. PubMed ID: 7692442
[TBL] [Abstract][Full Text] [Related]
2. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice.
Welsh M; Welsh N; Bendtzen K; Mares J; Strandell E; Oberg C; Sandler S
Diabetologia; 1995 Feb; 38(2):153-60. PubMed ID: 7536171
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic islet blood perfusion in the nonobese diabetic mouse: diabetes-prone female mice exhibit a higher blood flow compared with male mice in the prediabetic phase.
Carlsson PO; Sandler S; Jansson L
Endocrinology; 1998 Aug; 139(8):3534-41. PubMed ID: 9681505
[TBL] [Abstract][Full Text] [Related]
5. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
Gurlo T; Kawamura K; von Grafenstein H
J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice.
Suarez-Pinzon WL; Mabley JG; Strynadka K; Power RF; Szabó C; Rabinovitch A
J Autoimmun; 2001 Jun; 16(4):449-55. PubMed ID: 11437493
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of aminoguanidine administration and effects on the diabetes frequency in nonobese diabetic mice.
Bowman MA; Simell OG; Peck AB; Cornelius J; Luchetta R; Look Z; Maclaren NK; Atkinson MA
J Pharmacol Exp Ther; 1996 Nov; 279(2):790-4. PubMed ID: 8930185
[TBL] [Abstract][Full Text] [Related]
8. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM.
Corbett JA; McDaniel ML
Diabetes; 1992 Aug; 41(8):897-903. PubMed ID: 1378415
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide formation by aminoguanidine: an attempt to prevent insulin-dependent diabetes mellitus.
Holstad M; Jansson L; Sandler S
Gen Pharmacol; 1997 Nov; 29(5):697-700. PubMed ID: 9347312
[TBL] [Abstract][Full Text] [Related]
10. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
Corbett JA; Tilton RG; Chang K; Hasan KS; Ido Y; Wang JL; Sweetland MA; Lancaster JR; Williamson JR; McDaniel ML
Diabetes; 1992 Apr; 41(4):552-6. PubMed ID: 1376704
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
[TBL] [Abstract][Full Text] [Related]
12. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis.
Takamura T; Kato I; Kimura N; Nakazawa T; Yonekura H; Takasawa S; Okamoto H
J Biol Chem; 1998 Jan; 273(5):2493-6. PubMed ID: 9446547
[TBL] [Abstract][Full Text] [Related]
14. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide is important for mouse beta-cell line killing by peritoneal exudate cells obtained from cyclophosphamide treated non-obese diabetic mice.
Kasuga A; Nakaki T; Takei I; Takayama S; Ozawa Y; Maruyama T; Miyazaki J; Saruta T
Endocr J; 1995 Apr; 42(2):259-63. PubMed ID: 7542976
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
[TBL] [Abstract][Full Text] [Related]
17. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
McInerney MF; Flynn JC; Goldblatt PJ; Najjar SM; Sherwin RS; Janeway CA
J Immunol; 1996 Oct; 157(8):3716-26. PubMed ID: 8871675
[TBL] [Abstract][Full Text] [Related]
18. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
20. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
